⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19168030 | 1.00 | — | — | |
| SCHEMBL1628866 | 1.00 | — | — | |
| SCHEMBL17232123 | 1.00 | — | — | |
| SCHEMBL6424045 | 1.00 | — | — | |
| SCHEMBL561454 | 1.00 | — | — | |
| SCHEMBL19242845 | 0.75 | — | — | |
| SCHEMBL18266878 | 0.73 | — | — | |
| SCHEMBL16176584 | 0.73 | PTPN1 (0.32) | — | |
| SCHEMBL16176240 | 0.73 | PTPN1 (0.32) | — | |
| SCHEMBL16176245 | 0.73 | PTPN1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025224747-A1 | HIGH-CAPACITY MIXED CATION MULTI-IONIC CATHODES | GEGADYNE ENERGY LABS PRIVATE LIMITED (IN) | 2025-10-30 | — | — | WO | claimed |
| WO-2025224748-A1 | HIGH-CAPACITY HIGH-RATE MULTI-IONIC CATHODES | GEGADYNE ENERGY LABS PRIVATE LIMITED (IN) | 2025-10-30 | — | — | WO | claimed |
| WO-2025224751-A1 | HIGH-CAPACITY HIGH-VOLTAGE MULTI-IONIC CATHODES | GEGADYNE ENERGY LABS PRIVATE LIMITED (IN) | 2025-10-30 | — | — | WO | claimed |
| US-20170301481-A1 | QUANTUM DOTS-SENSITIZED SOLAR CELL AND METHOD OF ENHANCING THE OPTOELECTRONIC PERFORMANCE OF A QUANTUM DOTS-SENSITIZED SOLAR CELL USING A CO-ADSORBENT | NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (TW) | 2017-10-19 | — | — | US | claimed |
| WO-2009156622-A1 | ABSORBING SOLUTION CONTAINING A SULPHURATED ORGANIC DEGRADATION INHIBITOR AND METHOD FOR LIMITING THE DEGRADATION OF AN ABSORBING SOLUTION | IFP (FR) | 2009-12-30 | — | — | WO | claimed |
| US-6989263-B1 | Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2006-01-24 | — | — | US | claimed |
| US-6979431-B2 | Method for labelling technetium or rhenium using borohydride exchange resin | KOREA ATOMIC ENERGY RESEARCH INSTITUTE (KR) | 2005-12-27 | — | — | US | claimed |
| US-20030198648-A1 | Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to HIV-1 RNA | ACHILION PHARMACEUTICALS | 2003-10-23 | — | — | US | claimed |
| US-20030194365-A1 | Method for labelling technetium or rhenium using borohydride exchange resin | KOREA ATOMIC ENERGY RESEARCH INSTITUTE (KR) | 2003-10-16 | — | — | US | claimed |
| WO-2003060098-A2 | METHODS FOR IDENTIFYING COMPOUNDS WHICH INHIBIT BINDING OF NUCLEOCAPSID 7 PROTEIN TO HIV-1 RNA | ACHILLION PHARMACEUTICALS, INC. (US) | 2003-07-24 | — | — | WO | claimed |
| US-6001555-A | DISSOCIATING A ZINC FINGER BY CONTACTING THE PROTEIN WITH A DISULFIDE, A MALEIMIDE, AN ALPHA-HALOGENATED KETONE, A HYDRAZIDE, A NITRIC OXIDE OR DERIVATIVES, CUPRIC IONS, FERRIC IONS OR THEIR COMPLEXES; SYNERGISTIC EFFECTS WITH VIRICIDES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-12-14 | — | — | US | claimed |
| EP-0957903-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | Codon Pharmaceuticals, Inc. (US) | 1999-11-24 | — | — | EP | claimed |
| US-5990177-A | CYCLIC AND ACYCLIC MONO-, DI- AND TRIALCOHOLS AS STIMULANTS TO TREAT DISEASES MEDIATED BY DEFICIENCIES IN THE NITRIC OXIDE/CYCLIC GUANOSINE MONOPHOSPHATE/PROTEIN KINASE G SIGNAL TRANSDUCTION PATHWAY; CARDIOVASCULAR; SKIN; NERVOUS SYSTEM | CODON PHARMACEUTICALS, INC. (US) | 1999-11-23 | — | — | US | claimed |
| EP-0912546-A1 | IMPROVED RESERVOIR COMPONENTS | AUSTRALIAN MEMBRANE AND BIOTECHNOLOGY RESEARCH INSTITUTE (AU) | 1999-05-06 | — | — | EP | claimed |
| WO-1998055085-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | CODON PHARMACEUTICALS, INC. (US) | 1998-12-10 | — | — | WO | claimed |
| WO-1998011882-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | CODON PHARMACEUTICALS, INC. (US) | 1998-03-26 | — | — | WO | claimed |
| WO-1997043274-A1 | IMPROVED RESERVOIR COMPONENTS | AUSTRALIAN MEMBRANE AND BIOTECHNOLOGY RESEARCH INSTITUTE (AU) | 1997-11-20 | — | — | WO | claimed |
| EP-0782632-A1 | A METHOD FOR IDENTIFYING AND USING COMPOUNDS THAT INACTIVATE HIV-1 AND OTHER RETROVIRUSES BY ATTACKING HIGHLY CONSERVED ZINC FINGERS IN THE VIRAL NUCLEOCAPSID PROTEIN | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the Secretary of the Department of Health and Human Services (US) | 1997-07-09 | — | — | EP | claimed |
| WO-1996009406-A1 | A METHOD FOR IDENTIFYING AND USING COMPOUNDS THAT INACTIVATE HIV-1 AND OTHER RETROVIRUSES BY ATTACKING HIGHLY CONSERVED ZINC FINGERS IN THE VIRAL NUCLEOCAPSID PROTEIN | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-03-28 | — | — | WO | claimed |
| US-4690715-A | Modification of the properties of metals | AMERICAN TELEPHONE AND TELEGRAPH COMPANY, AT&T BELL LABORATORIES (US) | 1987-09-01 | — | — | US | claimed |